Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE CLINICAL TRIAL SUPPLIES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 SERVICES LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
5 EUROPE CLINICAL TRIAL SUPPLIES MARKET: REGULATORY SCENARIO
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE
6.1.2 INCREASING INCIDENCE OF CHRONIC DISEASES
6.1.3 GOVERNMENT FUNDS IN R&D INVESTMENTS
6.1.4 ADVANCEMENT OF TECHNOLOGY IN CLINICAL TRIALS SUPPLIES
6.2 RESTRAINTS
6.2.1 ADVERSE EFFECTS OF CLINICAL TRIALS
6.2.2 TRANSPORTATION ISSUE IN CLINICAL TRIAL SUPPLIES
6.2.3 HIGH COST ASSOCIATED WITH THE CLINICAL TRIALS
6.3 OPPORTUNITIES
6.3.1 INCREASING NEW DRUG DEVELOPMENT TRIALS IN EMERGING COUNTRIES
6.3.2 INCREASING DEMAND FOR INNOVATIVE SOLUTIONS IN CLINICAL TRIALS SERVICES
6.3.3 EVOLUTION IN SUPPLY CHAIN MANAGEMENT FOR CLINICAL TRIALS
6.4 CHALLENGES
6.4.1 LOWER PROCEDURE TIME OF CLINICAL TRIALS APPROVAL
6.4.2 LACK OF SKILLED PERSON TO OPERATE DEVICES DURING CLINICAL TRIALS
7 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES
7.1 OVERVIEW
7.2 STORAGE
7.3 MANUFACTURING
7.4 PACKAGING AND LABELLING
7.5 DISTRIBUTION
8 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASES
8.1 OVERVIEW
8.2 PHASE III
8.3 PHASE II
8.4 PHASE IV
8.5 PHASE I
9 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE
9.1 OVERVIEW
9.2 ONCOLOGY
9.3 CARDIOVASCULAR DISEASES
9.4 DERMATOLOGY
9.5 METABOLIC DISORDERS
9.6 INFECTIOUS DISEASES
9.7 RESPIRATORY DISEASES
9.8 CNS AND MENTAL DISORDERS
9.9 BLOOD DISORDERS
9.1 OTHERS
10 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY END USER
10.1 OVERVIEW
10.2 CONTRACT RESEARCH ORGANIZATIONS
10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
11 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY REGION
11.1 EUROPE
11.1.1 GERMANY
11.1.2 FRANCE
11.1.3 U.K.
11.1.4 ITALY
11.1.5 SPAIN
11.1.6 NETHERLANDS
11.1.7 RUSSIA
11.1.8 BELGIUM
11.1.9 TURKEY
11.1.10 SWITZERLAND
11.1.11 REST OF EUROPE
12 EUROPE CLINICAL TRIAL SUPPLIES MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: EUROPE
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENT
14.1.5.1 PARTNERSHIP
14.2 ALMAC GROUP
14.2.1 COMPANY SNAPSHOT
14.2.2 COMPANY SHARE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 CATALENT INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 SERVICE PORTFOLIO
14.3.5 RECENT DEVELOPMENT
14.3.5.1 SERVICE EXPANSION
14.4 CLINIGEN GROUP PLC
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENT
14.4.5.1 PARTNERSHIP
14.5 MOVIANTO
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 SERVICE PORTFOLIO
14.5.4 RECENT DEVELOPMENT
14.5.4.1 ACQUISITION
14.6 PCI PHARMA SERVICES
14.6.1 COMPANY SNAPSHOT
14.6.2 SERVICE PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 SHARP
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 ALIUM MEDICAL LIMITED
14.8.1 COMPANY SNAPSHOT
14.8.2 SERVICE PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 ANCILLARE, LP
14.9.1 COMPANY SNAPSHOT
14.9.2 SERVICE PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 BIOCAIR
14.10.1 COMPANY SNAPSHOT
14.10.2 SERVICE PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 BIONICAL LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 SERVICE PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.11.3.1 SERVICE LAUNCH
14.12 CLINICAL SUPPLIES MANAGEMENT HOLDINGS,INC
14.12.1 COMPANY SNAPSHOT
14.12.2 SERVICE PORTFOLIO
14.12.3 RECENT DEVELOPMENT
14.13 KLIFO
14.13.1 COMPANY SNAPSHOT
14.13.2 SERVICE PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.13.3.1 ACQUISTION
14.14 MYONEX
14.14.1 COMPANY SNAPSHOT
14.14.2 SERVICE PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 PAREXEL INTERNATIONAL CORPORATION
14.15.1 COMPANY SNAPSHOT
14.15.2 SERVICE PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.15.3.1 COLLABORATION
14.16 SIRO CLINPHARM PRIVATE LIMITED
14.16.1 COMPANY SNAPSHOT
14.16.2 SERVICE PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 LOCATIONS OF REGISTERED STUDIES
TABLE 2 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 3 EUROPE STORAGE IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 EUROPE MANUFACTURING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE PACKAGING AND LABELLING IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 EUROPE DISTRIBUTION IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 8 EUROPE PHASE III IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 EUROPE PHASE II IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 EUROPE PHASE IV IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 EUROPE PHASE I IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 13 EUROPE ONCOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE CARDIOVASCULAR DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 EUROPE DERMATOLOGY IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE METABOLIC DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE INFECTIOUS DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE RESPIRATORY DISEASES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE CNS AND MENTAL DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE BLOOD DISORDERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE OTHERS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 23 EUROPE CONTRACT RESEARCH ORGANIZATIONS IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN CLINICAL TRIAL SUPPLIES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 26 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 27 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 28 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 29 EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 30 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 31 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 32 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 33 GERMANY CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 34 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 35 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 36 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 37 FRANCE CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 38 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 39 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 40 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 41 U.K. CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 42 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 43 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 44 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 45 ITALY CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 46 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 47 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 48 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 49 SPAIN CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 51 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 52 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 53 NETHERLANDS CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 54 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 55 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 56 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 57 RUSSIA CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 58 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 59 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 60 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 61 BELGIUM CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 62 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 63 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 64 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 65 TURKEY CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 66 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
TABLE 67 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY CLINICAL PHASE, 2020-2029 (USD MILLION)
TABLE 68 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY THERAPEUTIC USE, 2020-2029 (USD MILLION)
TABLE 69 SWITZERLAND CLINICAL TRIAL SUPPLIES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 70 REST OF EUROPE CLINICAL TRIAL SUPPLIES MARKET, BY SERVICES, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 EUROPE CLINICAL TRIAL SUPLLIES MARKET: SEGMENTATION
FIGURE 2 EUROPE CLINICAL TRIAL SUPPLIES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CLINICAL TRIAL SUPPLIES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CLINICAL TRIAL SUPPLIES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE CLINICAL TRIAL SUPPLIES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CLINICAL TRIAL SUPLLIES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CLINICAL TRIAL SUPPLIES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE CLINICAL TRIAL SUPPLIES MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE CLINICAL TRIAL SUPPLIES MARKET: SEGMENTATION
FIGURE 10 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 11 RISING DEMAND FOR CLINICAL TRIALS WORLDWIDE AND INCREASING INCIDENCES OF DISEASES IS DRIVING THE EUROPE CLINICAL TRIAL SUPPLIES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 STORAGE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CLINICAL TRIAL SUPPLIES MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE CLINICAL TRIAL SUPPLIES MARKET
FIGURE 14 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2021
FIGURE 15 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, CAGR (2022-2029)
FIGURE 17 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES, LIFELINE CURVE
FIGURE 18 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2021
FIGURE 19 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, CAGR (2022-2029)
FIGURE 21 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY CLINICAL PHASE, LIFELINE CURVE
FIGURE 22 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2021
FIGURE 23 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, CAGR (2022-2029)
FIGURE 25 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY THERAPEUTIC USE, LIFELINE CURVE
FIGURE 26 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2021
FIGURE 27 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY END USER, CAGR (2022-2029)
FIGURE 29 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 EUROPE CLINICAL TRIAL SUPPLIES MARKET: SNAPSHOT (2021)
FIGURE 31 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021)
FIGURE 32 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE CLINICAL TRIAL SUPPLIES MARKET: BY SERVICES (2022-2029)
FIGURE 35 EUROPE CLINICAL TRIAL SUPPLIES MARKET: COMPANY SHARE 2021 (%)
